Mitochondrial complex I impairment in leukocytes from polycystic ovary syndrome patients with insulin resistance

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 9, 2009, Pages 3505-3512

  Victor, Victor M ^a,b   Rocha, Milagros ^a   Bañuls, Celia ^a,c   Sanchez Serrano, Maria ^a   Sola, Eva ^a   Gomez, Marcelino ^a   Hernandez Mijares, Antonio ^a,b,c  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRODE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; INSULIN RESISTANCE; LEUKOCYTE; MEMBRANE POTENTIAL; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; OXYGEN CONSUMPTION; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; SPECTROPHOTOMETRY; UNIVERSITY HOSPITAL;

EID: 69949091535     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0466     Document Type: Article

References (38)

1. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI 1999 A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84:4006-4011 (Pubitemid 30644187)
2. Ehrmann DA 2005 Polycystic ovary syndrome. N Engl J Med 352:1223-1236
3. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800 (Pubitemid 28009567)
4. Li M, Youngren JF, Dunaif A, Goldfine ID, Maddux BA, Zhang BB, Evans JL 2002 Decreased insulin receptor (IR) autophosphorylation in fibroblast from patients with PCOS: effects of serine kinase inhibitors and IR activators. J Clin Endocrinol Metab 87:4088-4093
5. Dunaif A, Xia J, Book CB, Schenker E, Tang Z 1995 Excessive insulin receptor serine phosphorylation in cultured fibroblast and in skeletal muscle: a potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 96:801-810
6. Højlund K, Staehr P, Hansen BF, Green KA, Hardie DG, Richter EA, Beck-Nielsen H, Wojtaszewski JF 2003 Increased phosphorylation of skeletal muscle glycogen synthase at NH2-terminal sites during physiological hyperinsulinemia in type 2 diabetes. Diabetes 52:1393-1402 (Pubitemid 36666193)
7. Kelley DE, He J, Menshikova EV, Ritov VB 2002 Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51:2944-2950
8. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI 2004 Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664-671 (Pubitemid 38364625)
9. Sreekumar R, Halvatsiotis P, Schimke JC, Nair KS 2002 Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 51:1913-1920 (Pubitemid 34564306)
10. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstråle M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC 2003 PGC-1α-responsive genes involved in oxidative phosphorylation are co-ordinately downregulated in human diabetes. Nat Genet 34:267-273 (Pubitemid 36792858)
11. Boirie Y, Short KR, Ahlman B, Charlton M, Nair KS 2001 Tissue specific regulation of mitochondrial and cytoplasmic protein synthesis rates by insulin. Diabetes 50:2652-2658 (Pubitemid 33733114)
12. Pitteloud N, Mootha VK, Dwyer AA, Hardin M, Lee H, Eriksson KF, Tripathy D, Yialamas M, Groop L, Elahi D, Hayes FJ 2005 Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care 28:1636-1642 (Pubitemid 41340902)
13. González F, Rote NS, Minium J, Kirwan JP 2006 Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab 91:336-340
14. González F, Rote NS, Minium J, Kirwan JP 2006 increased activation of nuclear factor κB triggers inflammation and insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab 91:1508-1512
15. González F, Rote NS, Minium J, Kirwan JP 2006 In Vitro evidence that hyperglycemia stimulates tumor necrosis factor-α release in obese women with polycystic ovary síndrome. J Endocrinol 188:521-529
16. 2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 119:573-581
17. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25
18. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR 2004 Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 89:453-462 (Pubitemid 38269843)
19. Solá E, Vayá A, Corella D, Santaolaria ML, España F, Estellés A, Hernández-Mijares A 2007 Erythrocyte hyperaggregation in obesity: determining factors and weight loss influence. Obesity 15:2128-2134
20. Núñez C, Víctor VM, Tur R, Alvarez-Barrientos A, Moncada S, Esplugues JV, D'Ocón P 2005 Discrepancies between nitroglycerin and NO-releasing drugs on mitochondrial oxygen consumption, vasoactivity, and the release of NO. Circ Res 97:1063-1069
21. Esplugues JV, Rocha M, Nuñez C, Bosca I, Ibiza S, Herance JR, Ortega A, Serrador JM, D'Ocon P, Victor VM 2006 Complex I dysfunction and tolerance to nitroglycerin: an approach based on mitochondrial-targeted antioxidants. Circ Res 99:1067-1075
22. Victor VM, De la Fuente M 2003 Immune redox state from mice with endotoxin-induced oxidative stress. Involvement of NF-κB. Free Radic Res 37:19-27
23. Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N 2001 Low grade chronic inflammation in women with polycystic ovary syndrome. J Clin Endocrinol Metab 86:2453-2455 (Pubitemid 32545690)
24. Orio Jr F, Giallauria F, Palomba S, Cascella T, Manguso F, Vuolo L, Russo T, Tolino A, Lombardi G, Colao A, Vigorito C 2006 Cardiopulmonary impairment in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 91:2967-2971 (Pubitemid 44271743)
25. Skov V, Glintborg D, Knudsen S, Jensen T, Kruse TA, Tan Q, Brusgaard K, Beck-Nielsen H, Højlund K 2007 Reduced expression of nuclear-encoded genes involved in mitochondrial metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome. Diabetes 56:2349-2355 (Pubitemid 47358242)
26. Højlund K, Beck-Nielsen H 2006 Impaired glycogen synthase activity and mitochondrial dysfunction in skeletal muscle: markers or mediators of insulin resistance in type 2 diabetes? Curr Diabetes Rev 2:375-395
27. Fleg JL, Piña IL, Balady GJ, Chaitman BR, Fletcher B, Lavie C, Limacher MC, Stein RA, Williams M, Bazzarre T 2000 Assessment of functional capacity in clinical and research applications: an advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association. Circulation 102:1591-1597
28. Rodnick KJ, Haskell WL, Swislocki AL, Foley JE, Reaven GM 1987 Improved insulin action in muscle, liver, and adipose tissue in physically trained human subjects. Am J Physiol 253:E489-E495
29. Clausen JO, Borch-Johnsen K, Ibsen H, Bergman RN, Hougaard P, Winther K, Pedersen O 1996 Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest 98:1195-1209 (Pubitemid 26299933)
30. Wood JR, Nelson VL, Ho C, Jansen E, Wang CY, Urbanek M, McAllister JM, Mosselman S, Strauss 3rd JF 2003 The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by Microarray analysis. J Biol Chem 278:26380-26390
31. Jansen E, Laven JS, Dommerholt HB, Polman J, van Rijt C, van den Hurk C, Westland J, Mosselman S, Fauser BC 2004 Abnormal gene expression profiles in human ovaries from polycystic syndrome patients. Mol Endocrinol 18:3050-3063 (Pubitemid 39577925)
32. Diao FY, Xu M, Hu Y, Li J, Xu Z, Lin M, Wang L, Zhou Y, Zhou Z, Liu J, Sha J 2004 The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA Microarray. J Mol Endocrinol 33:59-72 (Pubitemid 39206348)
33. Psarra AM, Sekeris CE 2008 Steroid and thyroid hormone receptors in mitochondria. IUBMB Life 60:210-223
34. De la Fuente M, Victor VM 2000 Antioxidants as modulators of immune function. Immunol Cell Biol 78:49-54
35. Victor VM, Rocha M, De la Fuente M 2004 Immune cells: free radicals and antioxidants in sepsis. Int Immunopharmacol 4:327-347 (Pubitemid 38375967)
36. Victor VM, Rocha M, Esplugues JV, De la Fuente M 2005 Role of free radicals in sepsis: antioxidant therapy. Curr Pharm Des 11:3141-3158 (Pubitemid 41149930)
37. de Cavanagh EM, Toblli JE, Ferder L, Piotrkowski B, Stella I, Inserra F 2006 Renal mitochondrial dysfunction in spontaneously hypertensive rats is attenuated by losartan but not by amlodipine. Am J Physiol Regul Integr Comp Physiol 290:R1616-R1625 (Pubitemid 43830828)
38. Esposito LA, Melov S, Panov A, Cottrell BA, Wallace DC 1999 Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci USA 96:4820-4825 (Pubitemid 29214495)